Apparatus for tissue cauterization

Information

  • Patent Grant
  • 8888770
  • Patent Number
    8,888,770
  • Date Filed
    Thursday, April 28, 2011
    13 years ago
  • Date Issued
    Tuesday, November 18, 2014
    10 years ago
Abstract
The invention is concerned with cauterizing and resecting tissue. A pair of electrodes are placed on opposed tissue surfaces, and radio frequency power is applied through the electrodes to cauterizing a tissue mass therebetween. After cauterization has been effected, the tissue may be resected along a plane within the cauterized region with minimum or no bleeding. The tissue mass may then be removed.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The invention relates generally to tissue cauterization. More particularly, the invention relates to an improved electrode for tissue cauterization.


2. Description of the Background Art


Tissue and organ removal are required in a number of surgical procedures for a number of purposes. A major concern in all tissue removal procedures is hemostasis, i.e., cessation of bleeding. All blood vessels supplying an organ or a tissue segment to be removed have to be sealed, either by suturing or cauterization, to inhibit bleeding when the tissue is removed. For example, when the uterus is removed in a hysterectomy, bleeding must be inhibited in the cervical neck which is resected, as well as along the vessels which supply blood to the uterus along its sides. Similarly, blood vessels within the liver must be individually sealed when a portion of the liver is resected in connection with removal of a tumor or for other purposes. The liver is a highly vascularized organ and sealing of the blood vessels is quite time consuming. Achieving hemostasis is necessary in both open surgical procedures and in minimally invasive surgical procedures. In the latter case, however, because of the limited access through cannula and other small passages, sealing of blood vessels can be even more time consuming and problematic.


Achieving hemostasis is particularly important in laparoscopic and other limited access procedures where the organ or other tissue must be morcellated prior to removal. Most organs are too large to be removed intact through a cannula or other limited access passage, thus requiring that the tissue be morcellated, e.g. cut, ground, or otherwise broken into smaller pieces, prior to removal. It will be appreciated that morcellation of vascularized tissue can be very problematic.


For these reasons, it would be desirable to provide improved methods, systems, and apparatus, for achieving hemostasis in connection with organ and tissue removal procedures. In particular, it would be desirable to provide methods and systems which permit a surgeon to achieve hemostasis in a time-efficient manner, using readily available surgical equipment e.g. radio frequency power supplies as discussed below, while reducing risk and trauma to the patient. It would be further desirable if the methods and systems are applicable to a wide variety of tissue removal procedures, including at least hysterectomies, liver tissue resection, cholecystectomies, prostate removal, lung resection, and the like. It would be still further desirable if the methods could provide for complete or substantially complete coagulation and hemostasis of an entire volume of tissue to be removed to facilitate such procedures as a subsequent morcellation. The ability to, for example, morcelate tissue while minimizing bleeding will be of substantial benefit to the performance of laparoscopic and other minimally invasive procedures, as well as other surgical procedures.


The use of radio frequency (RF) energy to necrose body organs or portions thereof is known. U.S. Pat. No. 4,979,948 describes a balloon electrode which is inflated in the interior of a uterus and used to apply RF energy to necrose the endothelial lining of the uterus. U.S. Pat. No. 3,845,771 describes a glove having flexible electrodes on the thumb and middle finger. The glove is intended for conducting RF current to conventional forceps, scalpels, etc. U.S. Pat. No. 4,972,846 describes electrode patch pairs useful as defibrillator leads which are engaged directly on the epicardium. U.S. Pat. Nos. 5,178,618 and 5,078,736 describe stents which can be energized to apply RF energy on the interior of a body lumen. Lorentzen et al. (1996) Min. Ivas. Ther. Allied Technol. 5:511-516 describes a loop electrode that can be rotated within tissue to excuse a tissue volume.


U.S. Pat. No. 6,203,541 discloses an automatic circuit that controls a surgical instrument, having a pair of bipolar electrodes. The circuit comprises a means for measuring the current between the pair of electrodes, an impedance detection circuit that is in electrical communication with the current measuring means, a comparator that has an electrical communication with the impedance detection circuit, and a controller that is electrically connected to the comparator. The impedance detection circuit calculates the impedance between the electrodes based on the measured currents and generates a first signal indicative of the calculated impedance. The comparator processes the first signal and generates an activation signal if the calculated impedance falls within a predetermined range of impedance values and generates a deactivation signal if the calculation impedance exceeds a deactivation threshold. The controller receives the activation and deactivation signals and transmits the first control signal to a radio frequency energy output stage to activate the electrodes in response to the activation signal and transmits the second control signal to the radio frequency output stage to deactivate the electrodes in response to the deactivation signal.


U.S. Pat. No. 6,398,779 teaches a method for electrosurgically sealing a tissue that concludes the steps of applying an initial pulse of RF energy to the tissue, the pulse having characteristics selected so as not to heat the tissue appreciably; measuring the value of the impedance of the tissue and response to the applied pulse; and in accordance with the measured impedance value, determining an initial set of pulse parameters for use during a first RF energy pulse as applied to the tissue. The invention teaches varying the pulse parameters of individual ones of subsequent RF energy pulses in accordance with at least one characteristic of an electrical transient that occurs during subsequent RF energy pulses. The method terminates the generation of subsequent RF energy pulses upon a determination that the electrical transient is absent or that a minimum output voltage has been reached.


U.S. Pat. No. 5,443,463 teaches a coagulating forceps for selectively coagulating blood vessels or tissue containing blood vessels. The method taught involves the placement of the blood vessels or tissue containing blood vessels between the prongs of the forceps, with the jaws of the forceps containing a plurality of electrodes which are energized by radio frequency power. A plurality of sensors are associated with the electrodes, and in contact with the vessels or tissue, to measure the temperature rise of the tissue or blood vessels and to provide a feedback to the radio frequency power to control the heating to perform coagulation of vessels or tissue. The invention also teaches that the upper prong of the device may be split into two parts with the cutting blade between the two upper parts to provide for cutting of the coagulated vessels subsequent to the coagulation.


SUMMARY OF THE INVENTION

The invention provides methods, systems, and apparatus which facilitate tissue cauterization in connection with such procedures as tissue resection and removal from patients undergoing a wide variety of procedures. The procedures may involve removal of an entire organ, e.g. hysterectomies, cholecystectomies, prostate removal, lung resection, and the like. Alternatively, the methods may involve removal of a portion of an organ or other tissue, such as tumor removal, often from highly vascularized organs, such as the liver, lung, or the like. The methods generally involve two steps, where the tissue is first necrosed or cauterized in whole or in part using radio frequency energy. In particular, the cauterization is effected at least along a desired resection plane within the tissue. The tissue is then resected along said plane(s). Advantageously, it has been found that resection within the necrosed or cauterized tissue substantially minimizes, and in some cases eliminates, the bleeding caused by the tissue resection. Preferably, the tissue cauterization is effected over a target volume of tissue, typically an entire organ or a portion thereof, e.g. the uterus, the lobe of a liver, a lung section, the prostate, or the like. By effecting substantially complete cauterization of a target tissue volume, the bleeding capacity of that tissue is reduced or eliminated, thus facilitating subsequent morcellization and tissue removal. Thus, organ and tissue removal is greatly facilitated with a substantial reduction in bleeding and the time needed for the surgical procedure.


In a first specific aspect, methods according to the invention comprise engaging at least a first electrode structure and a second electrode structure against spaced-apart surfaces of a tissue mass, typically against opposed surfaces of the tissue mass. The first and second electrode structures may have generally similar geometries to contact tissue in a symmetric fashion. Alternatively, the electrode structures may have dissimilar geometries, e.g. one of the electrode structures may be configured as a probe for insertion into a natural body orifice with the other electrode structure being configured for engagement against an exterior tissue surface spaced-apart from said orifice. In some instances, more than two electrode structures may be employed, but at least two electrode structures (or separate regions of a single structure) are energized with opposite polarity to provide for application of the radio frequency energy to the tissue. In some other instances, the electrode structures may be different regions formed as part of a single support structure, e.g. a single elastic tube or shell which may be placed over an organ or other tissue mass and which has two or more electrode surfaces formed thereon. The different electrode surfaces are, of course, isolated from each other when they are intended to apply high frequency energy of opposite polarities. It is equally important for the electrodes not be in contact if they are of like polarity as well. In still other instances, a single electrode structure may have a plurality of electrically conductive or active regions, where the electrically conductive regions may be energized with the same or an opposite polarity. In other instances, electrode structures may be provided with tissue-penetrating elements to enhance electrode-tissue contact and increase the total available area of the electrically active region(s) on the electrode structure to deliver high frequency energy to the tissue. The use of such tissue-penetrating elements may be in addition to or in place of the use of conformable or rigid surface electrodes. In all instances, the electrode structures, or electrically active regions thereof, are configured to engage a substantially continuous segment or portion of the tissue surface having a minimum area as set forth below. When tissue-penetrating elements are used, they typically are dispersed in a general uniform matter over the electrically active area of the electrode structure.


High frequency (usually radio frequency) power is applied to the tissue mass through the electrically active regions(s) of the electrode structures, and the power is applied for a time and in an amount sufficient to cauterize or necrose tissue between said electrodes, preferably at least along a desired resection plane. Often, a volume of the tissue is resected by morcellating, e.g. grinding, comminuting, cutting into small pieces, or the like. Such morcellation is greatly facilitated by necrosis of the target tissue volume. By necrosed, it is meant that the cells of the tissue have been killed and that bleeding of the tissue, upon subsequent resection, has been substantially inhibited. The tissue is usually resected along a plane within the necrosed tissue mass, with minimal bleeding as described above.


The electrically active regions of the electrode structures have an area of at least 1 cm2, more usually at least 2 cm2, often having areas of 5 cm2 or larger, more often having areas of 10 cm2 or larger, still more often having areas of 50 cm2 or larger. The electrodes may have a wide variety of characteristics, may generally be rigid, flexible, elastic, malleable, conformable, or the like. Preferably, the electrodes flexible to facilitate engagement of the electrode against, and conformance to, a tissue surface. In at least some instances, it is desirable to provide flexible, elastic electrodes which may be conformed about the outer periphery of a tissue or organ surface, where the elastic nature of the electrode assures firm engagement and electrode contact. In other instances, however, the electrodes may be specifically configured to have a desired geometry for engaging a particular tissue surface.


The high frequency energy applied to the organ or tissue is generally provided at radio frequency typically, but not limited to the range from 100 kHz to 10 MHz, usually from 200 kHz to 750 kHz. The power levels depend on the surface area and volume of tissue being treated, but generally fall within the range from 10 W to 500 W, usually from 25 W to 250 W, more usually from 50 W to 200 W. Power is usually applied at a level of from 1 W/cm2 to 500 W/cm2, more usually from 10 W/cm2 to 100 W/cm2. The power is applied for a time sufficient to raise the tissue temperature in the tissue mass being treated to above a threshold level required for cauterization or necrosis, usually being above at least 60° C., frequently being above 70° C., and often above 80° C., or higher. The application of energy should be limited, however, so that adjacent tissue is not significantly heated or otherwise damaged. The use of opposed, bipolar electrodes is particularly advantageous in this regard because it concentrates the energy flux between the electrodes and limits the effect on adjacent tissue which are not confined within the opposed electrodes. The resulting necrosed tissue may comprise substantially the entire organ being treated, or in other cases may comprise a more narrow region, e.g. a planar region.


In another aspect, the invention comprises systems including at least a plurality of electrodes, and a power supply that is connectable to the electrodes for applying, for example, bipolar, high frequency power therebetween. The electrodes may be configured generally as described above, and are usually carried by an electrosurgical probe to facilitate deployment. The probe may have a wide variety of configurations, but usually comprises at least a shaft and a handle for manipulating the shaft. The electrodes are mounted at a distal end of the shaft and are usually manipulable from the proximal end of the shaft so that they may be opened and closed relative to each other to engage and capture an organ or other tissue mass therebetween. The electrodes may have any of the properties described above, and may in particular comprise metallic or metalized mesh which can elastically engage and conform to tissue surfaces. The electrosurgical probes may be used in a conventional bipolar manner, i.e. where each electrode is powered at an opposite polarity. Alternatively, the electrode surfaces may be powered at the same polarity with another electrode or electrodes used for completing the high frequency circuit. Typically, the other electrode(s) are in the form of one or more probes which may be inserted into a natural body orifice or lumen or may be introduced into an organ or other tissue mass. The probe(s) may conform to a natural lumen and/or saline or other electrically conductive fluid may be introduced into the lumen to help establish the conductive path.


In a specific embodiment, an electrosurgical device may comprise a single conformable structure, such as an elastically or non-elastically expansible tubular member, e.g. an expansible tubular braid mesh. The electrodes are formed on a plurality of locations over the conformable support structure and are usually isolated from each other, e.g. either by applying insulation or by relying on the inherently non-conductive nature of the conformable support structure.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a conceptual illustration of the system and method of the invention employing a plurality of rigid, plate electrodes;



FIG. 2 illustrates an electrosurgical probe comprising an electrode structure configuration where each electrode structure comprises a plurality of electrically isolated active surfaces;



FIG. 3 is a block schematic diagram that illustrates a power generator according to the invention; and



FIG. 4 is a flow diagram showing an algorithm for power modulation according to the invention.





DESCRIPTION OF THE SPECIFIC EMBODIMENTS

The methods, systems, and apparatus of the invention are useful for treating a variety of organs, portions of organs, or other solid tissue regions in a patient. The organ or other tissue mass have spaced-apart tissue surfaces, usually opposed tissue surfaces, which are accessible to electrode structures and which permit the application of radio frequency power between said surfaces. The tissue surfaces may be readily accessible or may require pre-treatment to gain access, e.g. blunt dissection, resection of small tissues or blood vessels using conventional surgical techniques, or the like. Organs which may be treated by the invention include the uterus, liver, prostate, kidney, bowel, pancreas, lung, breast, muscle, and the like.


The organs and other tissue are treated with bipolar radio frequency power directed at target tissue regions which are defined by spaced-apart placement of the electrode structures. The radio frequency power may be supplied by conventional general purpose electrosurgical power supplies operated at any accepted frequency, typically in the ranges set forth above. Power supplies may employ conventional sinusoidal or non-sinusoidal wave forms and may operate with fixed or controlled power levels, where the voltage, current, or both may be selected. Suitable power supplies are available from commercial suppliers, such as Valleylab, Aspen, and Bovie. In some instances, it will be desirable to use impedance matching transformers between the power supply and the electrodes to enhance the efficiency of energy delivery.


The electrodes may be configured in any manner suitable for engaging a tissue surface. Thus, the electrodes can be rigid, flexible, elastic, inelastic (non-distensible), planar, non-planar, or the like, and may optionally employ tissue-penetrating elements to enhance electrical contact between the electrode structure and the tissue, as well as to increase the electrode area. Preferred electrode configurations are either conformable so that they can be engaged against and conform to widely differing tissue surfaces (see, for example, U.S. patent application Ser. No. 11/371,988, the entirety of which is incorporated herein by this reference thereto), or they are specifically configured to have a geometry intended to engage a particular organ or tissue geometry. In both instances, the electrode structures may further be provided with tissue-penetrating elements. Examples of each are discussed hereinafter.


One electrode configuration uses a metalized mesh which is both flexible and elastic. Such meshes are suitable for use on retractable electrodes, such as retractable electrodes useful for minimally invasive procedures. The meshes may be suspended on or between more rigid frame members, where the frame members may be themselves expanded or contracted to deploy the mesh electrodes. Such meshes are also useful for fabricating elastic tubes or shells which may be placed over an organ or tissue mass like a sock. In the case of such tubular electrodes, it often desirable to form two or more discrete electrode surfaces on a single mesh, where the electrode surfaces are isolated, usually by virtue of the material properties of the mesh itself, i.e. they are polymeric and non-conductive. The elastic meshes can be in the form of a braid or other woven structure, e.g. as described in U.S. Pat. Nos. 5,431,676; 5,234,425; and 4,018,230, the full disclosures of which are incorporated herein by reference. The use of radially expansible braid structures is desirable because the diameter of the tissue-receiving lumen therein can be controlled by axial elongation. That is, the braid can be expanded by shortening its length and contracted by extending its length. All such mesh and braid structures can be metalized by conventional electroless plating techniques. Suitable for metals for plating include gold, silver, copper, stainless steel, and combinations and alloys thereof. Suitable elastomeric mesh materials include a wide variety of elastomers. Suitable braided mesh materials include nylon and other generally non-distensible polymers.


All types of electrode structures may be configured to have a conductive surface and a non-conductive surface. This is usually accomplished by leaving one surface as an exposed metallic face, while the other surface of the electrode is covered or insulated. In the case of rigid electrodes, the insulation can be laminated, coated, or otherwise applied directly to the opposed surface. In the case of flexible and elastic electrodes, it is necessary that the insulating layer also be flexible so that it can be expanded and contracted together with the electrode without loss or removal. In some cases, it is desirable to employ a separate sheet of material which is expanded together with the electrode and which covers the face which is desired to be insulated.


Referring now to FIG. 1, a system 10 according to the invention comprises a first, compound electrode 12, a second electrode 14, and a radio frequency power supply 16. The first electrode comprises a plurality of rigid plates that are independently connected to one pole of the power supply 16 and the second electrode is a rigid plate connected to the opposite pole. In other embodiments, the second electrode could be non-rigid and could represent multiple electrodes as well. In fact, multiple return electrodes are preferable in certain cases. The electrodes 12 and 14 can be engaged against a tissue mass T to engage opposed surfaces thereof. Radio frequency power is then selectively applied to the tissue through any combination of the plurality of rigid plates which form electrode 12 (as discussed in greater detail below) to cauterize the mass of tissue which is captured between the electrodes 12 and 14 completely. After the tissue is cauterized, it may be resected along a line within the cauterized region of tissue. Advantageously, resection within the cauterized tissue minimizes bleeding and simplifies hemostasis.


For use in cauterizing the tissue of, for example, the uterus, conformable electrodes and may be placed over opposed exterior surfaces of the uterus. Rather than applying high frequency energy of opposite polarities, as generally described above, the electrodes may be powered at a common polarity by a power supply. A probe may be inserted into the uterine cavity and powered at the opposite polarity. In this way, the opposed tissue surfaces comprise the interior lining of the uterine cavity on the one hand and the exterior surface of the uterus on the other hand. In the case of the uterus, it is generally desirable to cauterize substantially the entire tissue mass, with the possible exception of the cervical neck. In the case of other body organs and tissue masses, however, it may be desirable to cauterize only a portion of the tissue. The high frequency energy can be directed to limited portions of the tissue by choosing the configurations of the electrodes.


Preferably, the electrodes comprise a plurality of different electrically conductive regions, where the regions may be electrically isolated from each other or may be electrically coupled to each other. Single electrode structures may include three, four, five and as many as ten or more discrete electrically conductive regions thereon. Such electrically conductive regions are usually defined by electrically insulating regions or structure therebetween. When it is desired that two or more of the electrically conductive regions be electrically coupled, small electrical connections can be provided to bridge the insulation between the regions. Usually, at least some of the isolated, electrically conductive regions on the electrode structures are powered at opposite polarities, and in some instances the methods of the invention can be performed using only a single electrode structure having multiple electrically conductive regions thereon. Alternatively, isolated, electrically conductive regions on a single electrode structure may be powered at the same polarity, where a primary purpose of the different regions is to control or configure the high energy electrical flux being delivered into the tissue mass. For example, it may be desirable to deliver high frequency electrical energy into spaced-apart regions of a tissue mass without cauterizing other areas in between or adjacent to the region to be cauterized. In such cases, the electrode structures can be configured by appropriate placement of the electrically conductive regions.



FIG. 2 illustrates a system 300 that comprises a pair of electrode structures 302 and 304. At least one of the electrode structures 304 comprises a plurality of individual electrically conductive strips 310 which are spaced apart such that they are electrically isolated from each other. In other embodiments, the conductive strips may be separated by an electrically insulating material. The electrically conductive strips 310 may be selectively powered at different polarities in virtually any pattern. Often, it is desirable to energize the strips so that adjacent strips have opposite polarities. Those skilled in the art will appreciate that the electrodes may be discrete or that they may be formed by such techniques as screening, electrodeposition, and the like.


To this point in the description, the electrically conducted surfaces of the electrode structures have generally comprised rigid or conformable components having continuous surface geometries, i.e. surface geometries which are selected to create an uninterrupted interface with the tissue surface against which they are engaged. In some instances, it may be desirable to provide additional structure or components on the electrode structures to enhance or increase the effective electrical contact area between the electrode structure and the tissue surface. In particular, it is often desirable to provide tissue-penetrating elements on the electrode structures to both enhance electrical contact, tie reduce electrical impedance between the electrode and the tissue and, more importantly, to increase the total surface contact area between the electrode and the tissue. The tissue-penetrating elements may be needles, pins, protrusions, channels, or the like, but are usually pins having sharpened distal tips so that they can penetrate through the tissue surface and into the underlying tissue mass. The pins may have depths in the rage from 1 mm to 5 cm, usually being from 3 mm to 1 cm. The diameters of the pins may be from 0.1 mm to 5 mm, usually being from 0.5 mm to 3 mm. Usually, the pins are evenly distributed over the tissue-contact area of an electrode structure, with a pin density in the range from 0.1 pin/cm2 to 10 pin/cm2, usually from 0.5 pin/cm2 to 5 pin/cm2. Usually, the pins or other tissue-penetrating elements are provided in addition to an electrically conductive conformable or rigid electrode surface, but in some instances the pins may provide the total electrically conductive or active area of an electrode structure.


A system comprising a pair plurality of electrode structures can include electrically conductive strips separated, for example, by insulating rods. In addition, however, tissue-penetrating pins can be disposed along each of the electrically conductive strips. It is appreciated that a plurality of pins are disposed along the length of each strip. The electrode structures are generally of a curved configuration so that they may be placed over a tubular body structure or tissue mass. It is appreciated, however, that the strips may be formed from conformable meshes which permit the electrode structures to be flattened out or to assume a wide variety of other configurations. Additionally, the insulating structures may also be formed from a flexible or conformable material, permitting further reconfiguration of the electrode structures.


The electrically conductive strips may be energized in an alternating polarity configuration. Most simply, adjacent strips are connected to opposite polls on a single power supply. It is a simple matter, however, to rearrange the electrical connections to power the strips in virtually any pattern. Moreover, it is also possible to isolate different regions of each strip electrically e.g. Nos. 1 and 2 to permit powering those regions at different polarities.


Using the system 300, a variety of different tissue cauterization patterns can be achieved by selective energization of different ones of the electrode surfaces or regions. By selectively energizing two adjacent electrode surfaces in a bipolar fashion, while leaving all other surfaces non-energized, a limited tissue region is cauterized. In contrast, by energizing other electrode surfaces e.g. Nos. 4, 5, 6, and 7, a much larger region is cauterized. Slightly different patterns are achieved depending on the precise pattern of electrode surface polarity. The electrode surfaces can be energized in an alternating pattern of polarity (+, +, −) to produce a tissue cauterization pattern. Patterns of (+, +, −); (+, +); (−, +, +, −) etc., could also be used to produce somewhat different patterns of cauterized tissue.



FIG. 2 illustrates an electrosurgical probe 50 that includes a pair of jaws 56 having a distal end 58 and a proximal end 60. Alternatively, this probe may comprise a shaft that is typically a cylinder sized for introduction through a conventional cannula of the type used in minimally invasive surgery. Thus, the shaft typically has a diameter in the range from 5 mm to 15 mm, usually being nominally 5 mm, 10 mm, or 12 mm, to be consistent with conventional cannulas. The length of the shaft typically in the range from 10 cm to 30 cm, with the particular range depending on the intended procedure.


The electrosurgical probe 50 includes a handle assembly 62 that is attached to the proximal end 60 of the jaws 56. The handle includes a lever assembly 64 which is connected to actuate the electrodes 304 after they are deployed. The handle also includes a coaxial connector for connecting the electrodes to an electrosurgical power supply, as described herein, although the electrodes may be powered by conventional power supplies as well. The electrosurgical probe 50 may be employed to cauterize and resect a portion of liver. For example, the probe may be introduced through a cannula, and the electrodes advanced and opened so that they can capture a portion of the liver L which is to be removed. After the electrodes are closed against opposed surfaces of the liver, the radio frequency energy may be applied, as described above. After the tissue is fully cauterized, it may be resected along any line within the necrosed tissue mass. Optionally, the electrosurgical probe may be used to cauterize a series of tissue masses adjacent each other to cauterize and resect a larger tissue mass than would be possible using only a single application of radio frequency energy.


In one embodiment, the electrodes may be used, for example, to cauterize and resect a uterus. The uterus comprises a main body having fallopian tubes extending from each side. In addition to the fallopian tubes, several large blood vessels extend generally from the midline of the uterus. The electrodes may be placed over the anterior and posterior surfaces of the uterus with the fallopian tubes remaining attached and extending outwardly from between the electrode structures. Depending upon the procedure, in some cases the fallopian tubes would be included in the sealed, cauterized, and dissected region and, in others, the choice may be not to seal and cauterize the fallopian tubes. This decision is based upon whether the ovaries are to be removed along with the uterus or not. Radio frequency power may then be applied to the uterus, typically at a power level in the range from 10 W/cm2 to 100 W/cm2 for a time in the range from 10 sec. to 20 min., until the body of the uterus is substantially completely necrosed. Because of the geometry of the electrodes the necrosed body of the uterus terminates along a line generally at the cervical end of the uterus, as well as along lines adjacent the fallopian tubes. The uterus may then be resected along lines within the cauterized tissue region but adjacent the cervix and fallopian tubes. Resection within the cauterized regions of the uterus substantially minimizes bleeding and facilitates hemostasis. The uterus may then be removed, either intact in the case of open surgical procedures. In the case of minimally invasive procedures, the uterus may optionally be morcellated (comminuted into small pieces) prior to removal.


In one embodiment of the invention, parallel electrodes are provided along the device, thus preventing positive-to-negative contact if opposing jaws and electrodes are brought into contact. In this embodiment, the oppositely charged electrodes that are mounted in the same jaws must be mounted in a non-conductive material to prevent shorting.


The jaws can be offset by a soft compressive material, such as a foam rubber, to prevent the electrodes from contacting, while assuring secure contact with all intermediate tissue. This embodiment of the invention can accommodate variable tissue thicknesses, which are expected to be likely over 5-10 cm of tissue.


To prevent local areas of high impedance from impacting the overall system impedance along the entire electrode, and thus potentially reducing the power output of the entire system as the voltage reaches its maximal capacity, multiple electrodes could be located physically in series. These electrodes may be powered simultaneously or in a repetitive sequential or other series. The electrodes may also be powered entirely independently of each other. In this manner, if one area that has already been well sealed and has thus reached high impedance value, it does not affect other regions in which the tissue is not yet sealed, and is thus at a lower impedance, i.e. impedance goes up as sealing occurs and this can limit power transmission. Each electrode or electron pair can have unique power and energy delivery profiles, based on the properties of the tissue in a specific electrode location/position.


As should be apparent from the disclosure herein, there is a benefit to using longer electrosurgery electrodes or other high-energy sealing impedance mechanisms to save operating time in a number of surgical procedures. For example, depending on the makeup of the tissue involved and its thickness along the length of tissue to be cauterized, geometry variations of both the electrosurgical jaws and power supply may be optimized to facilitate surgical removal of part or all of particular organs.


For example, the connective tissue or ligaments of the uterus are relatively thin and of relatively low impedance, i.e., less than three Ohms in many cases before energy is delivered to the tissue, based on animal models. However, this impedance is not constant, both along the length of tissue being cauterized, and during the course of cauterization. Therefore, a power supply with a capacity of, for example, less than 100 volts is not adequate to seal and coagulate all tissue and blood vessels supporting the organ fully because it is often necessary to ramp up the voltage after initially applying power to cauterize the tissue to maintain power levels in light of increasing impedance as the sealing and cauterization process progresses. Further, for thicker tissue or organs, such as the liver, lungs, or bowel, or for longer segments of tissue, significantly higher voltages are likely to be required. For more delicate tissues or locations, high voltage power energy levels may not be safe. In addition, due to the higher impedance of some of these organs and tissues, the power supply must have sufficient cut-off for discontinuing power to the organ at the end of the sealing cycle. Thus, the power supply should automatically terminate current flow to the tissue once the power supply has determined the completion of the sealing cycle. Although manually discontinuing power delivery is an option, it is less desirable because it is subjective and it is less likely to include an accurate analysis of the condition of the tissue or organ. The automatic feedback system disclosed herein prevents excessive heating or burning of surrounding healthy tissues and organs, as well as minimizing tissue adhesion to the electrodes, while assuring adequate vessel sealing. Therefore, the power supply herein has multiple adjustable settings that the user can select based on the organ to be treated. A prior characterization of each organ determines preset voltage limits and curves, as well as final shutdown (endpoint) parameters based on time, impedance, voltage, current, temperature or energy data, or some combination of these for each specific organ. Therefore, processes that optimize safety and efficacy for the specific procedure are used. Based on the degree of vascularity and size of the blood vessels present, various tissues and organs may require different settings as well.


Another embodiment of the invention runs a test burst of current through the tissue for a short, i.e. less than five seconds, time period, at a low, safe power level. The profile data generated during this period are quickly, i.e. less than five seconds, and automatically programmed into an algorithm that optimizes the voltage, energy, time, and/or power delivery based on the conditions determined during the test period to seal the tissue or organ safely and effectively.


Likewise, the geometry of the jaws/electrodes are optimized for each indication. The length of the jaws and handle segments is optimized for the length of the tissue and location to be sealed and dissected. The force and/or minimum compression gap generated by the jaws is optimized for the tissue selected as well. A minimum force is required to ensure adequate uniform sealing among the entire length of tissue. However, excessive force may result in undesired damage to the tissue and cause significant bleeding prior to the sealing process. The optimal compression force is either predetermined for each organ or the compression handles are designed to exert a predefined force level for a particular organ. In one embodiment of the invention, this is controlled via a slip clutch-type mechanism similar to a torque wrench, or by a travel limiter for the jaws. Thus, there are separate devices designed for each application or once device that could have multiple individual settings that are adjusted to predetermined settings for the organ or thickness of organ to be operated on or removed. In some embodiments, force may be adjusted automatically and dynamically by sensing pressure along the length of one or both jaws with one or more strain gauges associated therewith.


The force exerted by the jaws in other embodiments may be limited by the materials used for the jaws themselves. In the case of an organ or a tissue where the force required to compress and seal the tissue safely is low, a material with a lower flexural modulus may be more appropriate, while in a tissue that can be safely clamped at a higher level to assure effective sealing, a higher modulus material may be used.


In another embodiment, the thickness of the jaws is adjusted by inflating a hollow chamber within the jaws with a pressurized fluid.


The angle between the handles and the jaws of the device may also be optimized to the application. This is determined mainly by the angle of attack of the procedure in the surgical environment. Rather than an abrupt angle, the device may have a gentle or gradual curve for certain applications.


The cutting or dissecting portion of the process may be optimized for specific organs as well. In the case where the cutting is performed by a sharp-edged blade, the width of the blade may vary based on the thickness of the tissue or organ to be removed. The thickness of the cutting material may also be optimized based on how readily the specific thickness/tissue cuts. More tenacious tissue may require more of a saw motion or a thicker or serrated blade or scissor mechanism, which, again, is predetermined for a specific application. If high energy systems are used to dissect the tissue, these may also be optimized for the application, as previously described in the power supply section above.


With regard to a multiple electrode algorithm as taught herein, each electrode is treated independently in terms of energy transmission and RF cycle monitoring, modulation, and termination. The parameters to be monitored in the presently preferred embodiment of the invention are current, voltage, impedance, energy, power, time, and temperature. Any combination of these parameters may be monitored, as well as the values of other parameters. These values may be monitored in a mathematical model that combines them into a single algorithm that determines the quality of the RF sealing process based on prior empirical analysis. The energy and/or power output may be modulated to optimize artery and vein sealing in the shortest time possible, preferably less than one minute, and desirable less than 30 seconds, without excessive heat transmission that could damage surrounding healthy tissue or result in excessive heat that could bond the tissue to the electrode surface. The optimization of the cycle can be based on an algorithm program into the power generator software/firmware that modulates and ultimately terminates the cycle when conditions have been met that have been empirically determined to safely and repeatedly satisfy the conditions of the surgical procedure being performed. For example, reaching a certain impedance and/or temperature value and continuing the power level for a predetermined amount of time beyond this point, or reducing (or conversely increasing) the power level once a certain impedance and pressure or temperature threshold have been reached.


Once desiccation of tissue has occurred, impedance tends to reach a plateau and becomes less of a measure of the quality of the sealing process which occurs after the point that desiccation has begun. Therefore, impedance measurement alone may not be an accurate determinant of successful vessel/tissue sealing. Thus, multiple modulations, step functions, or continuous changes in power, voltage, and/or energy, are provided to optimize the sealing cycle. The cycle changes or modulation may result in upward or downward complex variable changes to optimize the blood vessel/tissue sealing conditions. As a result, each electrode or electrode pair may have different cycle times and power, current, voltage, and energy profiles as a result of the feedback data for the specific segment of tissue contacting the specific electrode. The modulation/determination program may be a complex algorithm based on monitoring multiple variables and responding to a combination of predetermined conditions to adjust and terminate the cycle.


With regards to these variables, the following are typical:


Power 10-1000 watts/channel or electrode pair, typically 100-500 watts/channel or electrode pair;


Impedance 2-500 Ohms, typically 2-200 Ohms;


Voltage 5-500 volts, typically 50-250 volts;


Time space 1-1200 seconds, typically 5-30 seconds; and


Energy 1-30,000 joules, typically 1,000-10,000 joules.


In a presently preferred embodiment, the power generator is comprised of a constant output power design as opposed to a constant voltage or constant current design. In the inventive design, the power output is manifested based upon the load on the system. Thus, if the system sees a very high impedance load, the voltage is maintained at a reasonable level to avoid arcing. In the application to which the power generator is put, i.e. electro-cauterization, the impedance range may vary between, for example, two ohms and 150 ohms during the cauterization of tissue. By applying constant power, the presently inventive power source provides significant current at low impedance to achieve initial desiccation when the tissue is first being cauterized and, as cauterization proceeds, to apply higher voltage to complete the tissue sealing process. Thus, the invention provides larger current and smaller voltage at the beginning of the cauterization process and a higher voltage and lower current at the sealing phase of the process. Control of such power generator only requires that the system monitor power.


In the presently preferred embodiment, the power source is provided with a mechanism for setting the desired power. This can in accordance with a profile or otherwise, as discussed below. Pulse width modulation is used in connection with a flyback transformer. The system charges a primary of the flyback transformer and produces a regulated output. The secondary may be regulated, for example 15 volts at a desired number of amperes to produce the desired power output. Based upon the period, as determined by the width of the pulse which charges the primary, the power curve is determined. Thus, the invention establishes a certain level of power in the primary of the flyback transformer and the same level of power is provided by the secondary without regard to impedance of the load, i.e. the tissue.


In the preferred embodiment invention, the power generator is a source of power for multiple electrodes in the electrical surgical appliance. Accordingly, the power generator is provided with a plurality of output channels, each of which is independently adjustable. In FIG. 3, a block diagram is provided that shows a electrical surgical appliance 300 including a plurality of electrodes 310 as discussed above in connection with FIGS. 1 and 2. The electrical surgical appliance includes a conductive path 55 which typically comprises a plurality of conductors, one for each power generator output channel, for receiving power from power generator 16, and a return path 360 for providing a ground path and/or feedback to a power generator which may comprise any of information concerning current, voltage, impedance, energy, power, and temperature. Appropriate sensors are provided in the electro-surgical appliance. For example, a thermistor can be used to sense temperature, while impedance can be measured between any two or more of the electrodes. Alternatively, a ground plane may be provided on one jaw of the electro-surgical appliance and the individual electrodes may be placed on the other jaw of the electro-surgical appliance, such that a path is provided from and addressed from the electrode through the return electrode. Thus, the one jaw may establish a ground plane for the electrodes that are placed on the other jaw. Additionally, the power generator may be connected to the electrodes at its positive and/or negative terminals. Accordingly, the electronics within the power generator may reassign the polarity and/or use of the various terminals 310 within the appliance in real time. For example, one of the electrodes, or terminals, may be retained as a impedance sensing element. In other embodiments of the invention, this element may be dedicated for purposes of sensing impedance throughout the process.


The power generator 16 is comprised of a power source 335 that has multiple outputs which are controlled by control electronics 50 and thus routed to the individual electrodes in the electro-surgical appliance, as discussed above. The multiple outputs are independently operated by a microprocessor or other control mechanism 330 and are readily modulated and assignable. Thus, an output may be assigned to any one or more of the electrode elements at a certain point in operation of a cauterization cycle, and may be dynamically reassigned at other points of time. For example, if the power source were a four channel power source and the electro-surgical device had 16 electrodes, then each channel may support four electrodes in electro-surgical device. However, this arrangement may be altered so that some channels support more electrodes than others.


The microprocessor 330 may be configured through a series of profiles 340 to operate the device with a power curve and power distribution amongst the various electrodes in accordance with the procedure to be performed. Thus, for a hysterectomy a certain profile may be established for the electro-surgical appliance, while for a liver procedure a different profile may be established. Additionally, a smart card reader 365 may be provided that both configures the system for a particular procedure and that provides memory for recording information as to the operation of the power generator during the procedure. For example, the application of power to each channel, impedance sensed, the temperature sensed, and the like is captured to document the procedure.



FIG. 4 is a flow diagram showing an algorithm for power modulation according to the invention. At the start of the process, the user determines the profile (400) to be applied for a particular procedure. For example, some tissues or procedures may require a higher initial power level and then provide a reduction in the power level during the cauterization process.


The probe (electro-surgical appliance) is positioned (405) and the power for the power source is turned on (410). The system initializes itself (415), for example by taking initial impedance readings along the various electrodes in the electro-surgical appliance to develop a profile for the tissue to be cauterized. Initialization may also include the taking of initial temperature readings, strain pressure readings which are indicative of the thickness of the tissue along the surgical appliance surface, and other readings. A pilot signal may be transferred through the electro-surgical appliance to determine these values. For example, an initial low voltage may be provided to measure impedance. In this way, a real time profile may be developed for the actual tissue to be cauterized that may be used as an adaptation to the pre-established profile for a particular procedure. Thus, the profile which is established for the procedure may be modified in accordance with measurements related to the tissue to be cauterized.


The system then sets thresholds (420) which determine when an endpoint is approached. These thresholds may be determined by measurements such as impedance, current, voltage, energy, power, and temperature. The thresholds may also operate in connection with a time element. Thus, when a threshold is reached, the system may continue to operate for a certain period of time to assure that an appropriate endpoint is reached, such that cauterization is complete. In some embodiments, power generator channels that are assigned to electrodes for portions of the tissue that have reached an endpoint may be reassigned to those electrodes that are still actively cauterizing tissue to provide additional power to the process and thus hasten its conclusion.


Power is applied to the electro-surgical appliance (425) to commence cauterization. The system monitors two or more parameters during this process and determines when a threshold is reached (430). Once the threshold is reached, an endpoint procedure (435) is implemented. The endpoint procedure may be as simple as ramping the power down or it may also involve setting a timer. It is important to note that the application of power, while constant across a wide range of impedance may be modulated during the process of cauterization such that a power curve is applied for the procedure. Because the invention provides multiple channels of power for multiple electrodes, some electrodes may reach an endpoint before others. In this case, power to these electrodes is terminated while power is continued to be applied to the other electrodes. Thus, each electrode may have a difference power curve that is modulated in real time. If all endpoints are not reached (440), then the process continues (445); else the power to the system is turned off (450) and the procedure is complete.


The electro-surgical appliance incorporates sensors for capturing various process parameters in real time in accordance with the algorithm. Thus, impedance may be measured between selected electrode pairs or groups of electrodes; temperature may be measured in connection with one or more physical transitions along the surface of the appliance; and the effect of cauterization may be measured with local strain gauges situated along the length of one or both probe jaws (in this embodiment, strain gauges may also be used to precompute a cauterization profile). In this regard, each electrode may be thought of as a separate device which is independently operated for a particular region along the surface of tissue that is contacted by the probe jaws.


Although the invention is described herein with reference to the preferred embodiment, one skilled in the art will readily appreciate that other applications may be substituted for those set forth herein without departing from the spirit and scope of the present invention. For example, in some embodiments the power generator senses whether or not tissue is present at each electrode at the beginning of a cauterization cycle by measuring any of impedance, pressure, or any combination of these and/or other parameters. If for any electrode pair no tissue is present, then such electrode pair is idle and an indication to this effect is provided to a power generator operator. The power generator may also provide a status indicator for each electrode pair is that indicates whether the sealing cycle is active or completed with regard to each electrode pair. In this embodiment, each electrode pair can comprise a mode status indicator, such as an LED for example, that indicates any of an idle, active, or complete condition, once a cauterization cycle is commenced.


Accordingly, the invention should only be limited by the claims included below.

Claims
  • 1. An apparatus for tissue cauterization, comprising: a plurality of electrodes configured for engagement against one or more surfaces of the tissue;a power supply having a plurality of channels that are connectable to the electrodes for applying radio frequency energy thereto, the power supply providing multiple, selectable settings that are based on a tissue to be cauterized, the power supply configured to provide a power delivery profile based on properties of the tissue in a specific electrode location;an automatic feedback system adapted to control the radio frequency energy output from the power supply in real time based upon monitoring by the automatic feedback system of at least two of the following parameters: current, voltage, impedance, energy, power, temperature, and time; anda control mechanism configured to supply radio frequency energy to the tissue through the electrodes from the power supply, and to apply the power via at least two of the electrodes to the tissue for a time and in an amount sufficient to cauterize tissue contacted by the electrodes;wherein the control mechanism is configured to set threshold values associated with the electrodes, the threshold values being provided for determining when an endpoint is approached;wherein the threshold values are determined to be reached based on the monitoring;wherein the apparatus comprises an algorithm program configured to implement an endpoint procedure when a threshold value of the threshold values is reached, wherein the algorithm program continues to provide power to the associated electrodes for a predetermined period of time after the threshold is reached such that an appropriate endpoint is reached so as to assure that cauterization is complete; andwherein the algorithm program is configured to implement an endpoint procedure for each of the plurality of electrodes, wherein power to some of the plurality of electrodes is terminated while power continues to be applied to the other electrodes.
  • 2. An apparatus as in claim 1, wherein at least one of the electrodes comprises a conformable, electrically conductive surface.
  • 3. An apparatus as in claim 1, wherein at least one of the electrodes comprises a rigid electrically conductive surface.
  • 4. The apparatus of claim 1, further comprising: a mathematical model that combines the monitored parameters into said algorithm program, said algorithm program configured to determine the quality of tissue sealing based on prior empirical analysis; wherein the power supply output is modulated to optimize tissue sealing by terminating a cauterization cycle when conditions have been met that have been empirically determined to safely and repeatedly satisfy conditions of a procedure being performed.
  • 5. The apparatus of claim 4, wherein the conditions comprise any of impedance, temperature, pressure, current, voltage, energy, and power; and wherein the modulation comprises any of: (a) continuing a power level for a predetermined amount of time beyond a predetermined point, (b) reducing the power level once a certain condition threshold has been reached, and (c) increasing the power level once a certain condition threshold has been reached.
  • 6. The apparatus of claim 4, wherein each electrode has any of different cycle times and power, current, voltage, and energy profiles as a result of feedback data for a specific segment of tissue contacting a specific electrode.
  • 7. The apparatus of claim 1, the power supply further comprising: a constant output power circuit.
  • 8. The apparatus of claim 1, the control mechanism being operable to set a desired power in accordance with a profile.
  • 9. The apparatus of claim 1, wherein each channel of the plurality of channels is independently adjustable to provide a source of power for each of the electrodes.
  • 10. The apparatus of claim 1, wherein the power supply is configured by one or more profiles to operate with a power curve and power distribution amongst the electrodes in accordance with a desired cauterization procedure.
  • 11. The apparatus of claim 1, further comprising: a smart card reader configured to read a smart card for use in configuring the power supply for a particular cauterization procedure, and to record information indicative of operation of the power supply during the cauterization procedure.
  • 12. The apparatus of claim 1, wherein the apparatus is configured to treat each electrode independently in terms of energy transmission and radio frequency cycle monitoring, modulation, and termination, and wherein each of the plurality of electrodes is configurable to have a different power curve that is modulated in real time.
  • 13. A method for tissue cauterization, comprising the steps of: engaging a plurality of electrodes against one or more surfaces of a tissue;connecting a power supply having a plurality of channels to the electrodes for applying radio frequency energy thereto, the power supply providing multiple, selectable settings that are based on a tissue to be cauterized, the power supply providing a power delivery profile based on properties of the tissue in a specific electrode location;controlling the radio frequency energy output from the power supply in real time based upon monitoring of at least two of the following parameters: current, voltage, impedance, energy, power, temperature, and time;supplying radio frequency energy to the tissue through the electrodes from the power supply, and applying the power via at least two of the electrodes to the tissue for a time and in an amount sufficient to cauterize tissue contacted by the electrodes;setting threshold values associated with the electrodes, the threshold values for determining when an endpoint is approached;wherein the threshold values are determined to be reached based on said monitoring of at least two of the following parameters: current, voltage, impedance, energy, power, temperature, and time;providing an algorithm program; andimplementing an endpoint procedure using the algorithm program when a threshold value of the threshold values is reached, wherein the algorithm program continues to provide power to the associated electrodes for a predetermined period of time after the threshold is reached such that an appropriate endpoint is reached so as to assure that cauterization is complete,wherein the step of implementing an endpoint procedure comprises implementing an endpoint procedure for each of the plurality of electrodes, wherein power to some of the plurality of electrodes is terminated while power continues to be applied to the other electrodes.
  • 14. The apparatus of claim 1, wherein the endpoint procedure comprises ramping the power down.
  • 15. The apparatus of claim 1, wherein the endpoint procedure is triggered in direct response to said threshold value of the threshold values being reached.
  • 16. An apparatus for tissue cauterization, comprising: a plurality of electrodes configured for engagement against one or more surfaces of the tissue;a power supply having a plurality of channels that are connectable to the electrodes for applying radio frequency energy thereto, the power supply providing multiple, selectable settings that are based on a tissue to be cauterized, the power supply configured to provide a power delivery profile based on properties of the tissue in a specific electrode location;an automatic feedback system adapted to control the radio frequency energy output from the power supply in real time based upon monitoring by the automatic feedback system of at least two of the following parameters: current, voltage, impedance, energy, power, temperature, and time; anda control mechanism configured to supply radio frequency energy to the tissue through the electrodes from the power supply, and to apply the power via at least two of the electrodes to the tissue for a time and in an amount sufficient to cauterize tissue contacted by the electrodes;wherein the control mechanism is configured to set threshold values associated with the electrodes, the threshold values being provided for determining when an endpoint is approached;wherein the threshold values are determined to be reached based on the monitoring;wherein the apparatus comprises an algorithm program configured to implement an endpoint procedure when a threshold value of the threshold values is reached, wherein the algorithm program continues to provide power to the associated electrodes for a predetermined period of time such that an appropriate endpoint is reached so as to assure that cauterization is complete,wherein the endpoint procedure comprises setting a timer, andwherein the algorithm program is configured to implement an endpoint procedure for each of the plurality of electrodes, wherein power to some of the plurality of electrodes is terminated while power continues to be applied to the other electrodes.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 11/382,652, filed May 10, 2006, now U.S. Pat. No. 7,942,874; which application claims priority to both U.S. Provisional Application No. 60/725,720, filed Oct. 11, 2005, and Application No. 60/680,937, filed May 12, 2005, the entirety of each of which is incorporated herein by reference hereto.

US Referenced Citations (428)
Number Name Date Kind
3356408 Stutz Dec 1967 A
3527224 Rabinowitz Sep 1970 A
3709215 Richmond Jan 1973 A
3742955 Battista et al. Jul 1973 A
3845771 Vise Nov 1974 A
3920021 Hiltebrandt Nov 1975 A
3970088 Morrison Jul 1976 A
4018230 Ochiai et al. Apr 1977 A
4041952 Morrison, Jr. et al. Aug 1977 A
4072153 Swartz Feb 1978 A
4094320 Newton et al. Jun 1978 A
4231372 Newton Nov 1980 A
4492231 Auth Jan 1985 A
4532924 Auth et al. Aug 1985 A
4590934 Malis et al. May 1986 A
4671274 Sorochenko Jun 1987 A
4972846 Owens et al. Nov 1990 A
4976717 Boyle Dec 1990 A
4979948 Geddes et al. Dec 1990 A
4998527 Meyer Mar 1991 A
5037379 Clayman et al. Aug 1991 A
5041101 Seder et al. Aug 1991 A
5059782 Fukuyama Oct 1991 A
5078736 Behl Jan 1992 A
5108408 Lally Apr 1992 A
5133713 Huang et al. Jul 1992 A
5151102 Kamiyama et al. Sep 1992 A
5156613 Sawyer Oct 1992 A
5178618 Kandarpa Jan 1993 A
5190541 Abele et al. Mar 1993 A
5207691 Nardella May 1993 A
5217030 Yoon Jun 1993 A
5234425 Fogarty et al. Aug 1993 A
5250074 Wilk et al. Oct 1993 A
5267998 Hagen Dec 1993 A
5269780 Roos Dec 1993 A
5269782 Sutter Dec 1993 A
5273524 Fox et al. Dec 1993 A
5277201 Stern Jan 1994 A
5281216 Klicek Jan 1994 A
5282799 Rydell Feb 1994 A
5290287 Boebel et al. Mar 1994 A
5295990 Levin Mar 1994 A
5300068 Rosar et al. Apr 1994 A
5300087 Knoepfler Apr 1994 A
5312023 Green et al. May 1994 A
5324289 Eggers Jun 1994 A
5330471 Eggers Jul 1994 A
5330502 Hassler et al. Jul 1994 A
5336229 Noda Aug 1994 A
5336237 Chin et al. Aug 1994 A
5341807 Nardella Aug 1994 A
5342381 Tidemand Aug 1994 A
5352223 McBrayer et al. Oct 1994 A
5352235 Koros et al. Oct 1994 A
5354336 Kelman et al. Oct 1994 A
5356408 Rydell Oct 1994 A
5374277 Hassler Dec 1994 A
5377415 Gibson Jan 1995 A
5391166 Eggers Feb 1995 A
5395369 McBrayer et al. Mar 1995 A
5396900 Slater et al. Mar 1995 A
5397320 Essig et al. Mar 1995 A
5403312 Yates et al. Apr 1995 A
5417687 Nardella et al. May 1995 A
5423814 Zhu et al. Jun 1995 A
5431676 Dubrul et al. Jul 1995 A
5438302 Goble Aug 1995 A
5443463 Stern et al. Aug 1995 A
5443470 Stern et al. Aug 1995 A
5445638 Rydell et al. Aug 1995 A
5447513 Davison et al. Sep 1995 A
5449355 Rhum et al. Sep 1995 A
5456684 Schmidt et al. Oct 1995 A
5458598 Feinberg et al. Oct 1995 A
5462546 Rydell Oct 1995 A
5472442 Klicek Dec 1995 A
5480399 Hebborn Jan 1996 A
5482054 Slater et al. Jan 1996 A
5484435 Fleenor et al. Jan 1996 A
5484436 Eggers et al. Jan 1996 A
5496312 Klicek Mar 1996 A
5496317 Goble et al. Mar 1996 A
5514134 Rydell et al. May 1996 A
5520698 Koh May 1996 A
5531744 Nardella et al. Jul 1996 A
5540684 Hassler, Jr. Jul 1996 A
5540685 Parins et al. Jul 1996 A
5542945 Fritzsch Aug 1996 A
5549637 Crainich Aug 1996 A
5556397 Long et al. Sep 1996 A
5558100 Cox Sep 1996 A
5558671 Yates Sep 1996 A
5562700 Huitema et al. Oct 1996 A
5562701 Huitema et al. Oct 1996 A
5562702 Huitema et al. Oct 1996 A
5562720 Stern et al. Oct 1996 A
5569243 Kortenbach et al. Oct 1996 A
5571100 Goble et al. Nov 1996 A
5573535 Viklund Nov 1996 A
5578052 Koros et al. Nov 1996 A
5599350 Schulze et al. Feb 1997 A
5601224 Bishop et al. Feb 1997 A
5603700 Daneshvar Feb 1997 A
5603711 Parins et al. Feb 1997 A
5611803 Heaven et al. Mar 1997 A
5624452 Yates Apr 1997 A
5637110 Pennybacker et al. Jun 1997 A
5637111 Sutcu et al. Jun 1997 A
5653692 Masterson et al. Aug 1997 A
5658281 Heard Aug 1997 A
5662662 Bishop et al. Sep 1997 A
5662676 Koninckx Sep 1997 A
5665085 Nardella Sep 1997 A
5665100 Yoon Sep 1997 A
5667526 Levin Sep 1997 A
5669907 Platt, Jr. et al. Sep 1997 A
5673840 Schulze et al. Oct 1997 A
5673841 Schulze et al. Oct 1997 A
5674184 Hassler, Jr. Oct 1997 A
5674220 Fox et al. Oct 1997 A
5675184 Matsubayashi et al. Oct 1997 A
5680982 Schulze et al. Oct 1997 A
5681282 Eggers et al. Oct 1997 A
5683385 Kortenbach et al. Nov 1997 A
5683388 Slater Nov 1997 A
5688270 Yates et al. Nov 1997 A
5693051 Schulze et al. Dec 1997 A
5697949 Giurtino et al. Dec 1997 A
5700261 Brinkerhoff Dec 1997 A
5702390 Austin et al. Dec 1997 A
5704534 Huitema et al. Jan 1998 A
5707369 Vaitekunas et al. Jan 1998 A
5709680 Yates et al. Jan 1998 A
5713896 Nardella Feb 1998 A
5715832 Koblish et al. Feb 1998 A
5718703 Chin Feb 1998 A
5720719 Edwards et al. Feb 1998 A
5728143 Gough et al. Mar 1998 A
5733283 Malis et al. Mar 1998 A
5735289 Pfeffer et al. Apr 1998 A
5735848 Yates et al. Apr 1998 A
5735849 Baden et al. Apr 1998 A
5741285 McBrayer et al. Apr 1998 A
5746750 Prestel et al. May 1998 A
5749895 Sawyer et al. May 1998 A
5755717 Yates et al. May 1998 A
5776130 Buysse et al. Jul 1998 A
5788662 Antanavich et al. Aug 1998 A
5797941 Schulze et al. Aug 1998 A
5810811 Yates et al. Sep 1998 A
5817091 Nardella et al. Oct 1998 A
5817092 Behl Oct 1998 A
5823066 Huitema et al. Oct 1998 A
5833689 Long Nov 1998 A
5836990 Li Nov 1998 A
5840077 Rowden et al. Nov 1998 A
5855576 LeVeen et al. Jan 1999 A
5860975 Goble et al. Jan 1999 A
5891142 Eggers et al. Apr 1999 A
5893835 Witt et al. Apr 1999 A
5893874 Bourque et al. Apr 1999 A
5931835 Mackey Aug 1999 A
5931836 Hatta et al. Aug 1999 A
5954720 Wilson et al. Sep 1999 A
5976128 Schilling et al. Nov 1999 A
5979453 Savage et al. Nov 1999 A
6003517 Sheffield et al. Dec 1999 A
6004319 Goble et al. Dec 1999 A
6030384 Nezhat Feb 2000 A
6050993 Tu et al. Apr 2000 A
6050995 Durgin Apr 2000 A
6056744 Edwards May 2000 A
6059766 Greff May 2000 A
6059782 Novak et al. May 2000 A
6066139 Ryan et al. May 2000 A
6068626 Harrington et al. May 2000 A
6071281 Burnside et al. Jun 2000 A
6074386 Goble et al. Jun 2000 A
6086586 Hooven Jul 2000 A
6090106 Goble et al. Jul 2000 A
6093186 Goble Jul 2000 A
6096037 Mulier et al. Aug 2000 A
6099550 Yoon Aug 2000 A
6123701 Nezhat Sep 2000 A
H1904 Yates et al. Oct 2000 H
6142992 Cheng et al. Nov 2000 A
6152920 Thompson et al. Nov 2000 A
6152932 Ternstrom Nov 2000 A
6162220 Nezhat Dec 2000 A
6174309 Wrublewski et al. Jan 2001 B1
6179832 Jones et al. Jan 2001 B1
6203541 Keppel Mar 2001 B1
6203542 Ellsberry et al. Mar 2001 B1
6206877 Kese et al. Mar 2001 B1
6210406 Webster Apr 2001 B1
6212426 Swanson Apr 2001 B1
6217894 Sawhney et al. Apr 2001 B1
6228084 Kirwan, Jr. May 2001 B1
6234178 Goble et al. May 2001 B1
6241139 Milliman et al. Jun 2001 B1
6245069 Gminder Jun 2001 B1
6254601 Burbank et al. Jul 2001 B1
6258085 Eggleston Jul 2001 B1
6277114 Bullivant et al. Aug 2001 B1
6283963 Regula Sep 2001 B1
6287304 Eggers et al. Sep 2001 B1
6290715 Sharkey et al. Sep 2001 B1
6293942 Goble et al. Sep 2001 B1
6293946 Thorne Sep 2001 B1
6296636 Cheng et al. Oct 2001 B1
6312430 Wilson et al. Nov 2001 B1
6322494 Bullivant et al. Nov 2001 B1
6327505 Medhkour et al. Dec 2001 B1
6334861 Chandler et al. Jan 2002 B1
6350274 Li Feb 2002 B1
6361559 Houser et al. Mar 2002 B1
6364879 Chen et al. Apr 2002 B1
6371956 Wilson et al. Apr 2002 B1
6391024 Sun et al. May 2002 B1
6391029 Hooven et al. May 2002 B1
6398779 Buysse et al. Jun 2002 B1
6398781 Goble et al. Jun 2002 B1
H2037 Yates et al. Jul 2002 H
6416509 Goble et al. Jul 2002 B1
6428550 Vargas et al. Aug 2002 B1
6436096 Hareyama Aug 2002 B1
6464702 Schulze et al. Oct 2002 B2
6485486 Trembly et al. Nov 2002 B1
6485489 Teirstein et al. Nov 2002 B2
6491690 Goble et al. Dec 2002 B1
6494881 Bales et al. Dec 2002 B1
6500176 Truckai et al. Dec 2002 B1
6514252 Nezhat et al. Feb 2003 B2
6517530 Kleven Feb 2003 B1
6520185 Bommannan et al. Feb 2003 B1
6533784 Truckai et al. Mar 2003 B2
6546933 Yoon Apr 2003 B1
6554829 Schulze et al. Apr 2003 B2
6564806 Fogarty et al. May 2003 B1
6565560 Goble et al. May 2003 B1
6565561 Goble et al. May 2003 B1
6584360 Francischelli et al. Jun 2003 B2
6610074 Santilli Aug 2003 B2
6616654 Mollenauer Sep 2003 B2
6616659 de la Torre et al. Sep 2003 B1
6619529 Green et al. Sep 2003 B2
6623482 Pendekanti et al. Sep 2003 B2
6626901 Treat et al. Sep 2003 B1
6645198 Bommannan et al. Nov 2003 B1
6645201 Utley et al. Nov 2003 B1
6648839 Manna et al. Nov 2003 B2
6652518 Wellman et al. Nov 2003 B2
6656177 Truckai et al. Dec 2003 B2
6666859 Fleenor et al. Dec 2003 B1
6673085 Berg Jan 2004 B1
6676660 Wampler et al. Jan 2004 B2
6682526 Jones et al. Jan 2004 B1
6682527 Strul Jan 2004 B2
6695840 Schulze Feb 2004 B2
6699245 Dinger et al. Mar 2004 B2
6719754 Underwood et al. Apr 2004 B2
6722371 Fogarty et al. Apr 2004 B1
6736814 Manna et al. May 2004 B2
6743229 Buysse et al. Jun 2004 B2
6746488 Bales Jun 2004 B1
6752154 Fogarty et al. Jun 2004 B2
6752803 Goldman et al. Jun 2004 B2
6770070 Balbierz Aug 2004 B1
6770072 Truckai et al. Aug 2004 B1
6808525 Latterell et al. Oct 2004 B2
6817974 Cooper et al. Nov 2004 B2
6821273 Mollenauer Nov 2004 B2
6837888 Ciarrocca et al. Jan 2005 B2
6840938 Morley et al. Jan 2005 B1
6843789 Goble Jan 2005 B2
6852108 Barry et al. Feb 2005 B2
6889089 Behl et al. May 2005 B2
6893435 Goble May 2005 B2
6896672 Eggers et al. May 2005 B1
6896673 Hooven May 2005 B2
6905506 Burbank et al. Jun 2005 B2
6913579 Truckai et al. Jul 2005 B2
6918907 Kelly et al. Jul 2005 B2
6918909 Ohyama et al. Jul 2005 B2
6923803 Goble Aug 2005 B2
6926712 Phan Aug 2005 B2
6929642 Xiao et al. Aug 2005 B2
6936048 Hurst Aug 2005 B2
6939346 Kannenberg et al. Sep 2005 B2
6953461 McClurken et al. Oct 2005 B2
6981628 Wales Jan 2006 B2
7033356 Latterell et al. Apr 2006 B2
7063699 Hess et al. Jun 2006 B2
7090637 Danitz et al. Aug 2006 B2
7090673 Dycus et al. Aug 2006 B2
7090685 Kortenbach et al. Aug 2006 B2
7094235 Francischelli Aug 2006 B2
7101371 Dycus et al. Sep 2006 B2
7101372 Dycus et al. Sep 2006 B2
7101373 Dycus et al. Sep 2006 B2
7118587 Dycus et al. Oct 2006 B2
7125409 Truckai et al. Oct 2006 B2
7137980 Buysse et al. Nov 2006 B2
7159750 Racenet et al. Jan 2007 B2
7166102 Fleenor et al. Jan 2007 B2
7169146 Truckai et al. Jan 2007 B2
7179254 Pendekanti et al. Feb 2007 B2
7195627 Amoah et al. Mar 2007 B2
7220260 Fleming et al. May 2007 B2
7238195 Viola Jul 2007 B2
7250048 Francischelli et al. Jul 2007 B2
7267677 Johnson et al. Sep 2007 B2
7270664 Johnson et al. Sep 2007 B2
7276068 Johnson et al. Oct 2007 B2
7278991 Morris et al. Oct 2007 B2
7291143 Swanson Nov 2007 B2
7364577 Wham et al. Apr 2008 B2
7367972 Francischelli et al. May 2008 B2
7410483 Danitz et al. Aug 2008 B2
7494039 Racenet et al. Feb 2009 B2
7506790 Shelton, IV Mar 2009 B2
7540872 Schechter et al. Jun 2009 B2
7641651 Nezhat et al. Jan 2010 B2
7794461 Eder et al. Sep 2010 B2
7803156 Eder et al. Sep 2010 B2
7862565 Eder et al. Jan 2011 B2
7942874 Eder et al. May 2011 B2
20010029367 Fleenor et al. Oct 2001 A1
20020062123 McClurken et al. May 2002 A1
20020062136 Hillstead et al. May 2002 A1
20020107514 Hooven Aug 2002 A1
20020124853 Burbank et al. Sep 2002 A1
20020128643 Simpson et al. Sep 2002 A1
20020151882 Marko et al. Oct 2002 A1
20020177848 Truckai et al. Nov 2002 A1
20020183738 Chee et al. Dec 2002 A1
20030078577 Truckai et al. Apr 2003 A1
20030144652 Baker et al. Jul 2003 A1
20030144653 Francischelli et al. Jul 2003 A1
20030158547 Phan Aug 2003 A1
20030171745 Francischelli et al. Sep 2003 A1
20030216726 Eggers et al. Nov 2003 A1
20030229344 Dycus et al. Dec 2003 A1
20030236549 Bonadio et al. Dec 2003 A1
20040006339 Underwood et al. Jan 2004 A1
20040010245 Cerier et al. Jan 2004 A1
20040068274 Hooven Apr 2004 A1
20040097919 Wellman et al. May 2004 A1
20040122423 Dycus et al. Jun 2004 A1
20040143263 Schechter et al. Jul 2004 A1
20040199226 Shadduck Oct 2004 A1
20040236320 Protsenko et al. Nov 2004 A1
20050010212 McClurken et al. Jan 2005 A1
20050015085 McClurken et al. Jan 2005 A1
20050021026 Baily Jan 2005 A1
20050021027 Shields et al. Jan 2005 A1
20050033276 Adachi Feb 2005 A1
20050033277 Clague et al. Feb 2005 A1
20050033278 McClurken et al. Feb 2005 A1
20050070895 Ryan et al. Mar 2005 A1
20050070978 Bek et al. Mar 2005 A1
20050090819 Goble Apr 2005 A1
20050096645 Wellman et al. May 2005 A1
20050096694 Lee May 2005 A1
20050107781 Ostrovsky et al. May 2005 A1
20050107784 Moses et al. May 2005 A1
20050113817 Isaacson et al. May 2005 A1
20050113820 Goble et al. May 2005 A1
20050119654 Swanson et al. Jun 2005 A1
20050131390 Heinrich et al. Jun 2005 A1
20050149073 Arani et al. Jul 2005 A1
20050171533 Latterell et al. Aug 2005 A1
20050187561 Lee-Sepsick et al. Aug 2005 A1
20050192633 Montpetit Sep 2005 A1
20050196421 Hunter et al. Sep 2005 A1
20050203500 Saadat et al. Sep 2005 A1
20050203504 Wham et al. Sep 2005 A1
20050209664 Hunter et al. Sep 2005 A1
20050226682 Chersky et al. Oct 2005 A1
20050256522 Francischelli et al. Nov 2005 A1
20050256524 Long et al. Nov 2005 A1
20050261676 Hall et al. Nov 2005 A1
20060025765 Landman et al. Feb 2006 A1
20060025812 Shelton, IV Feb 2006 A1
20060041254 Francischelli et al. Feb 2006 A1
20060052778 Chapman et al. Mar 2006 A1
20060052779 Hammill Mar 2006 A1
20060064084 Haemmerich et al. Mar 2006 A1
20060079872 Eggleston Apr 2006 A1
20060167451 Cropper Jul 2006 A1
20060190029 Wales Aug 2006 A1
20060199999 Ikeda et al. Sep 2006 A1
20060217709 Couture et al. Sep 2006 A1
20060226196 Hueil et al. Oct 2006 A1
20060229665 Wales et al. Oct 2006 A1
20060253117 Hovda et al. Nov 2006 A1
20060258954 Timberlake et al. Nov 2006 A1
20060259035 Nezhat et al. Nov 2006 A1
20060271037 Maroney et al. Nov 2006 A1
20060271042 Latterell et al. Nov 2006 A1
20060287674 Ginn et al. Dec 2006 A1
20060289602 Wales et al. Dec 2006 A1
20060293655 Sartor Dec 2006 A1
20070005061 Eder et al. Jan 2007 A1
20070062017 Dycus et al. Mar 2007 A1
20070073340 Shelton, IV et al. Mar 2007 A1
20070129726 Eder et al. Jun 2007 A1
20070173804 Wham et al. Jul 2007 A1
20070173805 Weinberg et al. Jul 2007 A1
20070173811 Couture et al. Jul 2007 A1
20070179497 Eggers et al. Aug 2007 A1
20070185405 Altobelli et al. Aug 2007 A1
20070244538 Eder et al. Oct 2007 A1
20070250113 Hegeman et al. Oct 2007 A1
20070265613 Edelstein et al. Nov 2007 A1
20080172052 Eder et al. Jul 2008 A1
20080221565 Eder et al. Sep 2008 A1
20080228179 Eder et al. Sep 2008 A1
20090157071 Wham et al. Jun 2009 A1
20090157072 Wham et al. Jun 2009 A1
20090157075 Wham et al. Jun 2009 A1
20090182323 Eder et al. Jul 2009 A1
20090198272 Kerver et al. Aug 2009 A1
20100042093 Wham et al. Feb 2010 A9
20100280508 Eder Nov 2010 A1
20100298823 Cao et al. Nov 2010 A1
20110184404 Walberg et al. Jul 2011 A1
Foreign Referenced Citations (81)
Number Date Country
2061215 Aug 1992 CA
0440385 Aug 1991 EP
0487269 May 1992 EP
0502268 Sep 1992 EP
0562195 Sep 1993 EP
0658333 Jun 1995 EP
0923907 Jun 1999 EP
0833593 Feb 2001 EP
0737446 Dec 2002 EP
0717960 Feb 2003 EP
0869742 May 2003 EP
0873089 Oct 2003 EP
0742696 Nov 2003 EP
1041933 Mar 2004 EP
1004277 Jul 2004 EP
0959786 Sep 2004 EP
0913126 Oct 2004 EP
0956827 Oct 2004 EP
1472984 Nov 2004 EP
1621146 Feb 2006 EP
1645237 Apr 2006 EP
0875209 May 2006 EP
1293170 Jun 2006 EP
1293169 Jul 2006 EP
1064886 Aug 2006 EP
1767164 Mar 2007 EP
1518498 Dec 2007 EP
1039862 May 2008 EP
1532933 May 2008 EP
1707143 Jun 2008 EP
1518499 Aug 2008 EP
1632192 Mar 2009 EP
1486177 Aug 2009 EP
1852081 Aug 2009 EP
1747761 Oct 2009 EP
2106764 Oct 2009 EP
9-501328 Oct 1994 JP
2003088534 Mar 2003 JP
2004049566 Feb 2004 JP
2005144193 Jun 2005 JP
WO9222257 Dec 1992 WO
WO9308754 May 1993 WO
WO9400060 Jan 1994 WO
WO9426179 Nov 1994 WO
WO 9426228 Nov 1994 WO
WO9502371 Jan 1995 WO
WO9605776 Feb 1996 WO
WO9616605 Jun 1996 WO
WO9623449 Aug 1996 WO
WO9724073 Jul 1997 WO
WO9724074 Jul 1997 WO
WO9812999 Apr 1998 WO
WO9843548 Oct 1998 WO
WO9853750 Dec 1998 WO
WO9923933 May 1999 WO
WO9952459 Oct 1999 WO
WO9956646 Nov 1999 WO
WO0013192 Mar 2000 WO
WO0013193 Mar 2000 WO
WO0112090 Feb 2001 WO
WO0135846 May 2001 WO
WO0154602 Aug 2001 WO
WO0158372 Aug 2001 WO
WO0158373 Aug 2001 WO
WO0182812 Nov 2001 WO
WO0224092 Mar 2002 WO
WO02058542 Aug 2002 WO
WO02067798 Sep 2002 WO
WO03088806 Oct 2003 WO
WO03103522 Dec 2003 WO
WO2004032596 Apr 2004 WO
WO2004032776 Apr 2004 WO
WO2004073490 Sep 2004 WO
WO2004098383 Nov 2004 WO
WO2005009213 Feb 2005 WO
WO2005034729 Apr 2005 WO
WO2005079901 Sep 2005 WO
WO2005115251 Dec 2005 WO
WO2006060431 Jun 2006 WO
WO2007002227 Jan 2007 WO
WO2007082061 Jul 2007 WO
Non-Patent Literature Citations (55)
Entry
(Arthrocare); Arthrocare receives clearance to market coblation-based devices for gynecology and laparoscopic surgery: clearance includes plasma forceps and 21 specific indications; Business Wire; p. 524; Oct. 25, 2001.
(Business Wire); Radiofrequency energy proven effective against leading cause of obstructive sleep apnea; Business Wire; p09140175; Sep. 14, 1998.
(Curon); Curon announces the publication of data supporting durability and effectiveness of STRETTA® system—positive one year follow-up data of U.S. clinical trial published in gastrointestinal endoscopy; PR Newswire; pNYTH10307022002; Feb. 7, 2002.
(Curon); Curon medical announces presentation of positive clinical study results of STRETTA® procedure for gastroesophageal reflux disease (GERD); PR Newswire; pNYW07920032002; Mar. 20, 2002.
(Enable); Enable medical introduces second generation bipolar scissors; Health Industry Today; pNA; Dec. 1998.
(Everest) Everest medical announces introduction of 3mm bipolar forceps; PR Newswire; p1002MNW021; Oct. 2, 1996.
(Everest) Everest medical discusses patent status: forecasts $1 million revenue first quarter: introduces next generation bipolar scissors; PR Newswire; pN/A; Mar. 31, 1994.
(Everest) Everest medical introduces new QUADRIPOLAR™ cutting forceps at the global congress for gynecologic endoscopy meeting; PR Newswire; p. 8927; Nov. 8, 1999.
(Everest) Everest medical reports record first quarter results: introduces next generation bipolar scissors; PR Newswire; pN/A; Apr. 19, 1994.
(Everest) Quadripolar cutting forceps introduced by Everest Medical; Health Industry Today; vol. 63; No. 1; pNA; Jan. 2000.
(Novare); U.S. patent issued for Novare Surgical Systems Cygnet® surgical clamp: Novare signs multi-year supply agreement with Boston Scientific; PR Newswire; pNA; Sep. 2, 2003.
Aoki et al.; Thoracoscopic resection of the lung with the ultrasonic scalpel; Ann thorac Surg; vol. 67; No. 4; pp. 1181-1183; Apr. 1999.
Bergamaschi et al.; Laparoscopic intracorporeal bowel resection with ultrasound versus electrosurgical dissection; JSLS; vol. 5; No. 1; pp. 17-20; Jan.-Mar. 2001.
Eichfeld et al.; Evaluation of ultracision in lung metastatic surgery; Ann Thorac Surg; vol. 70; No. 4; pp. 1181-1184; Oct. 2000.
ERBE Elektromedizin GmbH; ERBE BiClamp Brochure; http://www.erbe-med.com/erbe/media/Marketingmaterialien/85100-139—ERBE—EN—BiClamp—D024676.pdf; downloaded Jan. 24, 2011; 6 pgs.
Gyrus ACMI (an Olympus Company); PKS Seal (product page); http://www.gyrusacmi.com/user/display.cfm?display=product&pid=9024; downloaded Jan. 24, 2011; 1 page.
Gyrus Medical; Cutting Forceps (Product Information); downloaded Oct. 5, 2005.
Gyrus Medical; LP Scissors (Product Information); downloaded Oct. 5, 2005.
Gyrus Medical; Lyons™ Dissecting Forceps (Product Information); downloaded Oct. 5, 2005.
Gyrus Medical; Micro/Macro-Jaw Forceps (Product Information); downloaded Oct. 5, 2005.
Gyrus Medical; Seal™ Open Forceps (Product Information); downloaded Oct. 5, 2005.
Hayashi et al.; Experimental and clinical evaluation of the harmonic scalpel in thoracic surgery; Kurume Med J; vol. 46; No. 1; pp. 25-29; 1999.
Hefni et al.; Safety and efficacy of using the ligasure vessel sealing system for securing the pedicles in vaginal hysterectomy: randomized controlled trial; BJOG; vol. 112; No. 3; pp. 329-333; Mar. 2005.
Heniford et al.; Initial results with an electrothermal bipolar vessel sealer; Surg Endosc; vol. 15; No. 8; pp. 799-801; Aug. 2001.
Johnson & Johnson Gateway, LLC; The Gynecare Versapoint (Product Information); http://jnjgateway.com/home/jhtml?loc=USENG&page=view Content&id=edea000100001747&parentid=fc0de00100000334; downloaded Oct. 20, 2005.
Kamat et al.; Superiority of electrocautery over the suture method for achieving cervical cone bed hemostasis; Obstet Gynecol; vol. 102; No. 4; pp. 726-730; Oct. 2003.
Kennedy et al.; High-burst-strength, feedback-controlled bipolar vessel sealing; Surg Endosc; vol. 12; No. 6; pp. 876-878; Jun. 1998.
Kim et al.; Design and fabrication of a locomotive mechanism for capsule-type endoscopes using shape memory alloys (SMAs); IEEE/ASME Trans on Mechatronics; vol. 10; No. 1; pp. 77-86; Feb. 2005.
Kovac; Transvaginal hysterectomy: rationale and surgical approach; Obstet. Gynecol.; vol. 103; pp. 1321-1325; 2004.
Landman et al.; Evaluation of a vessel sealing system, bipolar electrosurgery, harmonic scalpel, . . . in a porcine model; J. urol; vol. 169; No. 2; pp. 697-700; Feb. 2003.
Levy, et al.; Update on hysterectomy: new technology and techniques; A Supp. To OBG Maganagement; Feb. 2003.
Levy, et al.; Use of a new vessel ligation device during vaginal hysterectomy (presentation abstract); presented at FIGO 2000; Washington, D.C.; 2000.
Lin et al.; Application of ultrasonic scalpel in gynecologic operative laparoscopy; Chin Med J (Engl.); vol. 114; No. 12; pp. 1283-1285; Dec. 2001.
Live Tissue Connect Technologies; company profile; (http://www.onemedplace.com/database/compdisplay—print.php?CompanyID=11508); 1 pg.; Oct. 19, 2010 (downloaded Feb. 7, 2011).
Lyons et al.; An innovative bipolar instrument for laparoscopic surgery; JSLS; vol. 9; No. 1; pp. 39-41; Jan.-Mar. 2005.
McClurken et al.; Collagen shrinkage and vessel sealing; Technical brief #300. Dover, NH: Tissue Link Medical; 2001.
Nojarov et al.; High-energy scissors mode; Phys Rev C Nucl Phys; vol. 51; No. 5; pp. 2449-2456; 1995. (http://arxiv.org/abs/nucl-th/9502001v1).
Parikh et al.; Three dimensional virtual reality model of the normal female pelvic floor; Annals of Bimedical Engineering; vol. 32; pp. 292-296; Feb. 2004.
Sages 2001 Hands-On Course I—Taking it the next level: advanced laparoscopic techniques; http://www.sages.org/01program/syllabi/ho1/ho1.html#schirme; 24 pgs.; downloaded Oct. 5, 2005.
Sages 2001 Nurses Program, Session 1; http://sages.org/01program/syllabi/nurse/nurse.html; downloaded Jan. 24, 2011; 5 pgs.
Srisombut et al.; Laparoscopic hysterectomy using laparoscopic coagulating shears: experience of 15 cases; J. Med Assoc Thai; vol. 83; No. 8; pp. 915-920; Aug. 2000.
Surgrx 510(K) Summary (# K031133); Palo Alto, CA; 5 pgs.; Jul. 3, 2003.
Treat; A new thermal device for sealing and dividing blood vessels; http://www.starioninstruments.com/PDFs/Treat.pdf; downloaded Jun. 29, 2005; 2 pgs.
Tyco Healthcare; The LigaSure Vessel Sealing System (Brochure); Apr. 2002; 8 pgs.
Valleylab Products; Valleylab Products—Electrosurgical Forceps: The surgeon's choice for quality and precision (product information); http://www.valleylab.com/product/es/accessories/forceps—over.html; downloaded Oct. 20, 2005.
Valleylab Products; Valleylab Products—Ligasure™ vessel sealing system (product information); http://www.valleylab.com/product/vessel—seal/index.html; downloaded Oct. 20, 2005.
Nezhat et al.; U.S. Appl. No. 08/948,282 entitled “Method and systems for organ resection,” filed Oct. 9, 1997.
Eder, Joseph C.; U.S. Appl. No. 12/200,798 entitled “Assisted systems and methods for performing transvaginal hysterectomies,” filed Aug. 28, 2008.
Koss et al.; U.S. Appl. No. 12/748,229 entitled “Impedance mediated power delivery for electrosurgery,” filed Mar. 26, 2010.
Koss et al.; U.S. Appl. No. 12/907,646 entitled “Impedance mediated control of power delivery for electrosurgery,” filed Oct. 19, 2010.
Kerver et al.; U.S. Appl. No. 13/070,391 entitled “Articulable electrosurgical instrument with a stabilizable articulation actuator,” filed Mar. 23, 2011.
Van Lue et al.; U.S. Appl. No. 13/110,848 entitled “Electrosurgical tissue sealing augmented with a seal-enhancing composition,” filed May 18, 2011.
Japanese Examination Report issued in related Japanese Application No. 2011-509759 dated Feb. 28, 2014.
Indian Examination Report issued in related Indian Application No. 4341/KOLP/2007, dated Feb. 27, 2014.
Korean Examination Report issued in related Korean Application No. 10-2009-7018104 dated Feb. 20, 2014.
Related Publications (1)
Number Date Country
20110202058 A1 Aug 2011 US
Provisional Applications (2)
Number Date Country
60725720 Oct 2005 US
60680937 May 2005 US
Continuations (1)
Number Date Country
Parent 11382652 May 2006 US
Child 13096912 US